Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

White House envisions $65 billion plan to battle future pandemics 

By Brian Buntz | September 7, 2021

Joe Biden

President Joe Biden poses for his official portrait Wednesday, March 3, 2021, in the Library of the White House. (Official White House Photo by Adam Schultz)

With President Biden’s popularity recently slipping to a new low, the White House has announced a sweeping plan to blunt the impact of future pandemics. In the proposal titled “American Pandemic Preparedness: Transforming Our Capabilities,” the White House argues that “critical work” is “needed to transform U.S. capabilities to respond rapidly and effectively to any future pandemic or high consequence biologic threat.”

The Biden administration is initially seeking Congress to back a $15 billion investment in the initiative. 

The proposal calls for a total of $65.3 billion investment in the next seven to 10 years. 

Of that total, $24 billion would support the discovery and development of novel vaccines. Another $12 billion would cover therapeutics, while $5 billion would support the development of diagnostics. 

 The proposal was drafted by Eric Lander, assistant to the President for science and technology and Jacob Sullivan, assistant to the President for National Security Affairs. 

The introduction of the proposal mentions the threat of natural pandemics as well as laboratory accidents and bioweapons. 

Biden has accused China of withholding information related to the pandemic’s origins, while Chinese officials have alleged that a U.S. lab was the source of the pandemic. 

To date, some 40 million Americans have had confirmed COVID-19 infections since the pandemic broke out. 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

institut pasteur dakar IPD African Union vaccine investment
African Union vaccine initiative receives $45M
Sen-Jam Pharma, KVK-Tech partnering for manufacturing and formulation for anti-inflammatory injectables
This image shows the Moderna logo.
Moderna resizes its manufacturing footprint for a post-pandemic era
This is the logo of Pfizer.
Pfizer to close Durham and Morrisville, North Carolina facilities amid major restructuring effort
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE